Superworth10x Genomics profit margin TXG
Gross, operating and net profit as a share of revenue over the last twelve months, from 2018.
- Net margin, 12 months
- −12.2%
- Operating margin, 12 months
- −14.3%
- Net margin on a year earlier
- +0.9 pts
- Peer median
- 10.1%
Over the twelve months to Jun 30, 2026, 10x Genomics kept −12.2% of its revenue as net profit, with an operating margin of −14.3% and a gross margin of 70.0%.
The median for 10 diagnostics and research stocks of a similar size is 10.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −6.8% | −9.5% | 69.1% |
| FY2024 | −29.9% | −31.9% | 67.9% |
| FY2023 | −41.2% | −42.9% | 66.2% |
| FY2022 | −32.1% | −32.5% | 76.7% |
| FY2021 | −11.9% | −10.7% | 84.9% |
| FY2020 | n/a | n/a | 80.4% |
| FY2019 | −12.7% | −12.4% | 75.2% |
| FY2018 | −76.9% | n/a | 80.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −12.2% | +0.9 pts | −14.3% | |
| Q1 FY26 | −3.5% | +21.6 pts | −6.1% | |
| Q4 FY25 | −6.8% | +23.1 pts | −9.5% | |
| Q3 FY25 | −11.9% | +17.1 pts | −14.2% | |
| Q2 FY25 | −13.1% | +24.8 pts | −15.6% | |
| Q1 FY25 | −25.1% | +17.1 pts | −27.6% | |
| Q4 FY24 | −29.9% | +11.3 pts | −31.9% | |
| Q3 FY24 | −29.0% | +8.8 pts | −31.7% | |
| Q2 FY24 | −38.0% | −7.6 pts | −40.1% | |
| Q1 FY24 | −42.3% | −9.7 pts | −43.9% | |
| Q4 FY23 | −41.2% | −9.1 pts | −42.9% | |
| Q3 FY23 | −37.8% | −4.6 pts | −39.5% |
Against its peers
Companies in Medical - Diagnostics & Research nearest 10x Genomics' size, closest first, today.
| Company | Profit margin |
|---|---|
| TXG10x Genomics | −12.2% |
| CAICaris Life Sciences | 10.6% |
| BIOBio-Rad Laboratories | 8.6% |
| LNTHLantheus | 17.7% |
| BLLNBillionToOne | 9.5% |
| RVTYRevvity | 8.2% |
| MEDPMedpace | 17.7% |
| VCYTVeracyte | 20.4% |
| CDNACareDx | 24.2% |
| LHLabcorp | 7.0% |
| DGXQuest Diagnostics | 9.2% |
| Peer median | 10.1% |
Where 10x Genomics ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on 10x Genomics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.